Long COVID research: what's become clearer and what remains genuinely unresolved

Long COVID research has established that symptoms persisting well beyond acute infection are real, measurable, and biologically grounded rather than purely psychological — studies have documented objective findings including persistent inflammation markers, autonomic nervous system dysfunction, and in some patients, viral persistence in tissue reservoirs beyond the acute infection period, providing biological mechanisms for symptoms that were sometimes dismissed early in the pandemic.

Post-exertional malaise — symptom worsening after physical or cognitive exertion, sometimes delayed by a day or more — has emerged as a particularly important and distinct symptom pattern, overlapping considerably with the pattern seen in myalgic encephalomyelitis/chronic fatigue syndrome, and current clinical guidance for long COVID patients experiencing this pattern generally recommends pacing and activity management rather than the graded exercise therapy once more broadly recommended for fatigue conditions, since graded exercise has been shown to worsen symptoms in patients with genuine post-exertional malaise.

Treatment remains largely symptom-management focused rather than curative, since no single approved treatment addresses the underlying condition directly — multidisciplinary long COVID clinics, where available, generally show better patient-reported outcomes than single-specialist management, likely reflecting the genuinely multi-system nature of the condition that a single specialty often can't fully address alone.